Some
frequently cited epidemiologic studies have found an increased
correlation between elevated IGF - 1 and breast, prostate, and colorectal cancers, while the majority of studies failed to
document increased risk of cancer (or have shown a decreased risk) with increasing IGF - 1 levels.